Synthesis,Spectroscopic Studies,and Crystal Structures of Phenylorganotin Derivatives with [Bis(2,6‐dimethylphenyl)amino]benzoic Acid: Novel Antituberculosis Agents

The novel triphenyl adduct of 2‐(2,6‐dimethylphenyl)amino]benzoic acid (HDMPA; 1 ), i.e., SnPh₃(DMPA)] ( 2 ), the dimeric tetraorganostannoxane Ph₂(DMPA)SnOSn(DMPA)Ph₂]₂ ( 3 ), and the monomeric adduct SnPh₂(DMPA)₂] ( 4 ), where DMPA is monodeprotonated HDMPA, have been prepared and structurally characterized by means of IR, ¹H‐NMR, and ¹³C‐NMR spectroscopy. The structures of 1 and 2 have been determined by X‐ray crystallography. Single‐crystal X‐ray‐diffraction analysis of 1 revealed that there are two molecules in the asymmetric unit, HD1 and HD2 , differing in conformation, both forming centrosymmetric dimers linked by H‐bonds between the carboxylic O‐atoms. X‐Ray analysis of 2 revealed a pentacoordinate structure containing Ph₃Sn coordinated to the carboxylato group. Significant C? H/π interactions and intramolecular H‐bonds stabilize the structures of 1 and 2 , which self‐assembled via C? H/π and π/π‐stacking interactions. The Ph₃Sn adduct 2 was found to be a promising antimycobacterial lead compound, displaying activity against Mycobacterium tuberculosis H37Rv. The cytotoxiciy in the Vero cell line is also reported.